Editorial | Properly supervised, weight-loss drugs have a place in Hong Kong
While ensuring that Hongkongers who need the drugs have access to them, the authorities must act against the grey market for the medication
The use of weight-loss drugs has transformed the treatment of obesity, a chronic disease so prevalent globally it has been described as an epidemic. Injections that suppress appetite have changed the lives of millions. The new drugs were endorsed conditionally by the World Health Organization in December and are seen as a powerful clinical tool offering hope.
Injections obtained in this way might be counterfeit and prove ineffective or dangerous. The medication may have been improperly stored or transported. There is, therefore, a risk of serious harm, even death. Medical supervision is required to establish the correct dose and monitor how the patient responds. The drugs are usually only recommended for adults with a body mass index of 30 or above.
The illegal sale or possession of such products can lead to a fine of up to HK$100,000 (US$12,800) and a prison sentence of two years. Anyone tempted to buy them without a prescription should be aware of the consequences. Retail platforms must be careful not to permit such sales and the Department of Health needs to make good on its promise to investigate suspected abuses.
The fight against obesity must continue, including the use of weight-loss drugs. But they need to be approached with care and caution, under the guidance of healthcare professionals.